Dynamics of Respiratory Syncytial Virus Illness and Serology During Pregnancy and Infancy in the United States and South Africa
These findings suggest that the effectiveness of maternal immunization against infant RSV relies on immunization shifting natural distribution of maternal RSV neutralizing titers into the protective range for infants, which is supported by efficacy demonstrated with RSV maternal immunization.
Authors
- Agnieszka Zareba (ORCID: https://orcid.org/0000-0003-4118-6879)
- Kena A. Swanson (ORCID: https://orcid.org/0000-0002-3389-8414)
- Nicola P. Klein (ORCID: https://orcid.org/0000-0003-1777-4814)
- Philip R. Dormitzer (ORCID: https://orcid.org/0000-0003-0671-6360)
- Alejandra Gurtman (ORCID: https://orcid.org/0000-0003-3469-1201)
- Shabir Ahmed Madhi (ORCID: https://orcid.org/0000-0002-7629-0636)
- Eric A. F. Simões (ORCID: https://orcid.org/0000-0001-5588-2723)
- William C. Gruber (ORCID: https://orcid.org/0000-0002-6518-4547)
- Beate Schmöele-Thoma (ORCID: https://orcid.org/0000-0003-4632-357X)
- Daniel A. Scott (ORCID: https://orcid.org/0000-0002-4916-145X)
- Kathrin U. Jansen (ORCID: https://orcid.org/0000-0001-7818-8996)
- David Cooper (ORCID: https://orcid.org/0000-0002-4595-3943)
- Bing Cai (ORCID: https://orcid.org/0000-0002-3632-9866)
Institutions
- South African Medical Research Council (ZA)
- Kaiser Permanente (US)
- Pfizer (United States) (US)
- University of the Witwatersrand (ZA)
- Kaiser Permanente Oakland Medical Center (US)
- Children's Hospital Colorado (US)
- Pfizer (Germany) (DE)
- University of Colorado Denver (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-06-28
- DOI
- https://doi.org/10.1093/ofid/ofaf386
- Citations
- 2
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- Pfizer
- Sanofi
- Sanofi Pasteur